The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 7, 2013, Pages 4219-4225

  Huang, Jin ^a   Huang, Jichong ^a   Ma, Yaxian ^a   Wang, Haichuan ^a   Yang, Jiqiao ^a   Xiong, Tianyuan ^a   Du, Liang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer; Meta analysis; Polymorphism; VDR

Indexed keywords

ADENINE; GUANOSINE; TRANSCRIPTION FACTOR CDX2; CALCITRIOL RECEPTOR; CDX-2-3 PROTEIN; HOMEODOMAIN PROTEIN; TRANSACTIVATOR PROTEIN;

AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; GENE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; VDR GENE; ALLELE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MALE; META ANALYSIS; NEOPLASM; PUBLISHING; RISK;

ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; MALE; NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RECEPTORS, CALCITRIOL; RISK; TRANS-ACTIVATORS;

EID: 84879415381     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2503-9     Document Type: Article

References (22)

1. de Jongh RT, Lips P, Rijs KJ, van Schoor NM, Kramer MH, Vandenbroucke JP, Dekkers OM (2011) Associations between vitamin D receptor genotypes and mortality in a cohort of older Dutch individuals. Eur J Endocrinol/Eur Fed Endocr Soc 164(1):75-82
2. Zhou W, Heist RS, Liu G, Neuberg DS, Asomaning K, Su L, Wain JC, Lynch TJ, Giovannucci E, Christiani DC (2006) Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 15(11):2239-2245
3. Lee YH, Choi SJ, Ji JD, Song GG (2012) Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: a meta-analysis. Mol Biol Rep 39(6):6471-6478
4. Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, Hankinson SE (2009) Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 69(5):1885-1891
5. Mohammadnejad Z, Ghanbari M, Ganjali R, Afshari JT, Heydarpour M, Taghavi SM, Fatemi S, Rafatpanah H (2012) Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Mol Biol Rep 39(2):831-837
6. Anderson LN, Cotterchio M, Cole DE, Knight JA (2011) Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev 20(8):1708-1717
7. Bentley RW, Keown DA, Gearry RB, Cameron VA, Keenan J, Roberts RL, Day AS (2012) Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study. N Z Med J 125(1356):47-51
8. Flugge J, Krusekopf S, Goldammer M, Osswald E, Terhalle W, Malzahn U, Roots I (2007) Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol 63(11):997-1005
9. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT (2007) Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 16(12):2566-2571
10. Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, Giovannucci E (2007) Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate 67(9):911-923
11. Han J, Colditz GA, Hunter DJ (2007) Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 28(2):390-397
12. John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA (2005) Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 65(12):5470-5479
13. Zhang YG, Li XB, Zhang J, Huang J, He C, Tian C, Deng Y, Wan H, Shrestha D, Yang YY, Fan H (2011) The I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis. Allergy 66(2):197-205
14. Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J (2008) Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 10(2):31
15. Ochs-Balcom HM, Cicek MS, Thompson CL, Tucker TC, Elston RC, Plummer SJ, Casey G, Li L (2008) Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis 29(9):1788-1793
16. Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, Kukalizch K, Affleck P, Leake S, Haynes S, Karpavicius B, Marsden J, Gerry E, Bale L, Bertram C, Field H, Barth JH, Silva Idos S, Swerdlow A, Kanetsky PA, Barrett JH, Bishop DT, Bishop JA (2009) Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 45(18):3271-3281
17. Rowland GW, Schwartz GG, John EM, Ingles SA (2013) Protective effects of low calcium intake and low calcium absorption vitamin d receptor genotype in the california collaborative prostate cancer study. Cancer Epidemiol Biomarkers Prev 22(1):16-24
18. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG, Campbell H (2008) Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding. Int J Cancer 123(9):2170-2179
19. Torkko KC, van Bokhoven A, Mai P, Beuten J, Balic I, Byers TE, Hokanson JE, Norris JM, Baron AE, Lucia MS, Thompson IM, Leach RJ (2008) VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. Clin Cancer Res 14(10):3223-3229
20. Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, Sucheston LE, Tang L, Roberts M, Ciupak G, Davis W, Hwang H, Johnson CS, Trump DL, McCann SE, Ademuyiwa F, Pawlish KS, Bandera EV, Ambrosone CB (2012) Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast cancer Res 14(2):58
21. Liu C, Yin Q, Li L, Zhuang YZ, Zu X, Wang Y (2013) APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis. Mol Biol Rep 40(1):171-176
22. Xiao L, Tong M, Jin Y, Huang W, Li Z (2013) The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis. Mol Biol Rep 40(2):1835-1841